Bruker Corp at Jefferies Healthcare Conference (Virtual) Transcript
All right. Good morning, and thanks for joining us. Welcome to the Jefferies 2021 Virtual Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools in diagnostics sector here at the firm. It is my great pleasure to have Bruker with us at the conference again this year.
Joining us from the company today, Chairman, President and CEO, Dr. Frank Laukien; as well as Juergen Srega, who heads up the Bruker CALID Group. I'll turn it over to Frank to make some opening remarks, and then we'll jump into Q&A. Frank?
Yes, Brandon, great to be back. And with Juergen again, almost every year, we do that. Normally, it's ASMS time around the time of the Jefferies Healthcare Conference. This year, the big Mass Spectrometry Conference was pushed to the fall, but we nevertheless launched some very important products for proteomics yesterday, and I'll talk about that in a moment. And of course, that's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |